COMPUTER-ASSISTED DOSING OF HEPARIN

被引:43
作者
KERSHAW, B
WHITE, RH
MUNGALL, D
VANHOUTEN, J
BRETTFELD, S
机构
[1] WILLIAM BEAUMONT HOSP,DEPT PHARM,ROYAL OAK,MI
[2] FERRIS STATE SCH PHARM,BIG RAPIDS,MI
[3] BEAUMONT HOSP,DEPT PHARM,TROY,MI
关键词
D O I
10.1001/archinte.154.9.1005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Expert consultation by means of established practice guidelines has been shown to lead to improved accuracy of inpatient anticoagulation therapy, with a reduction in the frequency of hemorrhagic complications. We evaluated a different strategy to improve the accuracy of in-hospital anticoagulation: pharmacy-based; computer-assisted dosing of intravenous heparin therapy. Methods: Patients treated with computer-assisted dosing of heparin (N = 131) were compared with a randomly selected historical cohort (N = 57) in whom heparin therapy was managed by the primary physician. All patients treated by the pharmacy team received a bolus of heparin, 70 U/kg of ideal body weight, except for patients with pulmonary embolism, who received 100 U/kg of ideal body weight. A computer-generated infusion dose was selected (generally 13 to 16 U/kg per hour). The target was an activated partial thromboplastin time (APTT) ratio of 1.8 times the patient's baseline APTT, with a therapeutic range of 1.5 to 2.5 times baseline. Computer-assisted dosage recommendations were generated after each APTT measurement. Results: In the historical control group, 62% of the patients achieved a therapeutic APTT during the first 24 hours; 17% failed to reach a therapeutic level by 48 hours. The median time to reach a therapeutic APTT was 15 hours. Of all 696 APTTs in this group, 42% were below, 43% in, and 15% above the therapeutic range. In the computer-assisted group, 90% achieved a therapeutic APTT within 24 hours (P < .001); 97% had a therapeutic APTT by 48 hours (P < .01). The median time to achieve a therapeutic APTT was 7 hours (P < .001). Of all 880 APTTs in this group, 17% were below, 75% in, and 8% above the therapeutic range (P < .001). Conclusions: Pharmacy-based, computer-assisted dosing of heparin is feasible and results in faster and more accurate anticoagulant dosing.
引用
收藏
页码:1005 / 1011
页数:7
相关论文
共 19 条
[1]  
COE JM, 1979, AM J CLIN PATHOL, V72, P74
[2]   A STANDARD HEPARIN NOMOGRAM FOR THE MANAGEMENT OF HEPARIN-THERAPY [J].
CRUICKSHANK, MK ;
LEVINE, MN ;
HIRSH, J ;
ROBERTS, R ;
SIGUENZA, M .
ARCHIVES OF INTERNAL MEDICINE, 1991, 151 (02) :333-337
[3]   AUDIT OF CONTROL OF HEPARIN TREATMENT [J].
FENNERTY, AG ;
THOMAS, P ;
BACKHOUSE, G ;
BENTLEY, P ;
CAMPBELL, IA ;
ROUTLEDGE, PA .
BRITISH MEDICAL JOURNAL, 1985, 290 (6461) :27-28
[4]   HEPARIN KINETICS IN VENOUS THROMBOSIS AND PULMONARY-EMBOLISM [J].
HIRSH, J ;
VANAKEN, WG ;
GALLUS, AS ;
DOLLERY, CT ;
CADE, JF ;
YUNG, WL .
CIRCULATION, 1976, 53 (04) :691-695
[5]  
HIRSH J, 1988, THROMB HAEMOSTASIS, V59, P129
[6]   HEPARIN - MECHANISM OF ACTION, PHARMACOKINETICS, DOSING CONSIDERATIONS, MONITORING, EFFICACY, AND SAFETY [J].
HIRSH, J ;
DALEN, JE ;
DEYKIN, D ;
POLLER, L .
CHEST, 1992, 102 (04) :S337-S351
[7]   HEPARIN FOR 5 DAYS AS COMPARED WITH 10 DAYS IN THE INITIAL TREATMENT OF PROXIMAL VENOUS THROMBOSIS [J].
HULL, RD ;
RASKOB, GE ;
ROSENBLOOM, D ;
PANJU, AA ;
BRILLEDWARDS, P ;
GINSBERG, JS ;
HIRSH, J ;
MARTIN, GJ ;
GREEN, D .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (18) :1260-1264
[8]   CONTINUOUS INTRAVENOUS HEPARIN COMPARED WITH INTERMITTENT SUBCUTANEOUS HEPARIN IN THE INITIAL TREATMENT OF PROXIMAL-VEIN THROMBOSIS [J].
HULL, RD ;
RASKOB, GE ;
HIRSH, J ;
JAY, RM ;
LECLERC, JR ;
GEERTS, WH ;
ROSENBLOOM, D ;
SACKETT, DL ;
ANDERSON, C ;
HARRISON, L ;
GENT, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (18) :1109-1114
[9]   OPTIMAL THERAPEUTIC LEVEL OF HEPARIN-THERAPY IN PATIENTS WITH VENOUS THROMBOSIS [J].
HULL, RD ;
RASKOB, GE ;
ROSENBLOOM, D ;
LEMAIRE, J ;
PINEO, GF ;
BAYLIS, B ;
GINSBERG, JS ;
PANJU, AA ;
BRILLEDWARDS, P ;
BRANT, R .
ARCHIVES OF INTERNAL MEDICINE, 1992, 152 (08) :1589-1595
[10]   ANTITHROMBOTIC THERAPY FOR VENOUS THROMBOEMBOLIC DISEASE [J].
HYERS, TM ;
HULL, RD ;
WEG, JG .
CHEST, 1992, 102 (04) :S408-S425